4.6 Review

The Aryl Hydrocarbon Receptor: Connecting Immunity to the Microenvironment

Journal

TRENDS IN IMMUNOLOGY
Volume 39, Issue 12, Pages 1005-1020

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.it.2018.10.010

Keywords

-

Categories

Funding

  1. NIH [AR067763, CA190449]
  2. Medicine by Design/Canada First Research Excellence Fund (TLM) [C1TPA-2016-20]
  3. NATIONAL CANCER INSTITUTE [R01CA190449] Funding Source: NIH RePORTER
  4. NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR067763] Funding Source: NIH RePORTER

Ask authors/readers for more resources

The aryl hydrocarbon receptor (AhR) is a cytoplasmic receptor and transcription factor activated through cognate ligand binding. It is an important factor in immunity and tissue homeostasis, and structurally diverse compounds from the environment, diet, microbiome, and host metabolism can induce AhR activity. Emerging evidence suggests that AhR is a key sensor allowing immune cells to adapt to environmental conditions and changes in AhR activity have been associated with autoimmune disorders and cancer. Furthermore, AhR agonists or antagonists can impact immune disease outcomes identifying AhR as a potentially actionable target for immunotherapy. In this review, we describe known ligands stimulating AhR activity, downstream proinflammatory and suppressive mechanisms potentiated by AhR, and how this understanding is being applied to immunopathology to help control disease outcomes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available